135 related articles for article (PubMed ID: 10747038)
1. Efficient repair of A/C mismatches in mouse cells deficient in long-patch mismatch repair.
Oda S; Humbert O; Fiumicino S; Bignami M; Karran P
EMBO J; 2000 Apr; 19(7):1711-8. PubMed ID: 10747038
[TBL] [Abstract][Full Text] [Related]
2. Role of MutSalpha in the recognition of iododeoxyuridine in DNA.
Berry SE; Loh T; Yan T; Kinsella TJ
Cancer Res; 2003 Sep; 63(17):5490-5. PubMed ID: 14500385
[TBL] [Abstract][Full Text] [Related]
3. Role for mismatch repair proteins Msh2, Mlh1, and Pms2 in immunoglobulin class switching shown by sequence analysis of recombination junctions.
Schrader CE; Vardo J; Stavnezer J
J Exp Med; 2002 Feb; 195(3):367-73. PubMed ID: 11828012
[TBL] [Abstract][Full Text] [Related]
4. Interactions of the DNA mismatch repair proteins MLH1 and MSH2 with c-MYC and MAX.
Mac Partlin M; Homer E; Robinson H; McCormick CJ; Crouch DH; Durant ST; Matheson EC; Hall AG; Gillespie DA; Brown R
Oncogene; 2003 Feb; 22(6):819-25. PubMed ID: 12584560
[TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo modulations of benzo[c]phenanthrene-DNA adducts by DNA mismatch repair system.
Wu J; Zhu BB; Yu J; Zhu H; Qiu L; Kindy MS; Gu L; Seidel A; Li GM
Nucleic Acids Res; 2003 Nov; 31(22):6428-34. PubMed ID: 14602900
[TBL] [Abstract][Full Text] [Related]
6. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins.
Bucci B; D'Agnano I; Amendola D; Citti A; Raza GH; Miceli R; De Paula U; Marchese R; Albini S; Felsani A; Brunetti E; Vecchione A
Clin Cancer Res; 2005 Apr; 11(7):2756-67. PubMed ID: 15814658
[TBL] [Abstract][Full Text] [Related]
7. Nuclear translocation of mismatch repair proteins MSH2 and MSH6 as a response of cells to alkylating agents.
Christmann M; Kaina B
J Biol Chem; 2000 Nov; 275(46):36256-62. PubMed ID: 10954713
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the DNA mismatch repair proteins expression in malignant melanomas.
Korabiowska M; Brinck U; Dengler H; Stachura J; Schauer A; Droese M
Anticancer Res; 2000; 20(6B):4499-505. PubMed ID: 11205295
[TBL] [Abstract][Full Text] [Related]
9. DNA loop repair by human cell extracts.
Umar A; Boyer JC; Kunkel TA
Science; 1994 Nov; 266(5186):814-6. PubMed ID: 7973637
[TBL] [Abstract][Full Text] [Related]
10. Mlh1 can function in antibody class switch recombination independently of Msh2.
Schrader CE; Vardo J; Stavnezer J
J Exp Med; 2003 May; 197(10):1377-83. PubMed ID: 12743174
[TBL] [Abstract][Full Text] [Related]
11. Signaling mismatch repair in cancer.
Fishel R
Nat Med; 1999 Nov; 5(11):1239-41. PubMed ID: 10545986
[TBL] [Abstract][Full Text] [Related]
12. Four novel MSH2 / MLH1 gene mutations in portuguese HNPCC families.
Isidro G; Veiga I; Matos P; Almeida S; Bizarro S; Marshall B; Baptista M; Leite J; Regateiro F; Soares J; Castedo S; Boavida MG
Hum Mutat; 2000 Jan; 15(1):116. PubMed ID: 10612836
[TBL] [Abstract][Full Text] [Related]
13. Differential involvement of the human mismatch repair proteins, hMLH1 and hMSH2, in transcription-coupled repair.
Leadon SA; Avrutskaya AV
Cancer Res; 1997 Sep; 57(17):3784-91. PubMed ID: 9288788
[TBL] [Abstract][Full Text] [Related]
14. The role of DNA mismatch repair in platinum drug resistance.
Fink D; Nebel S; Aebi S; Zheng H; Cenni B; Nehmé A; Christen RD; Howell SB
Cancer Res; 1996 Nov; 56(21):4881-6. PubMed ID: 8895738
[TBL] [Abstract][Full Text] [Related]
15. Analysis of yeast pms1, msh2, and mlh1 mutators points to differences in mismatch correction efficiencies between prokaryotic and eukaryotic cells.
Yang Y; Karthikeyan R; Mack SE; Vonarx EJ; Kunz BA
Mol Gen Genet; 1999 Jun; 261(4-5):777-87. PubMed ID: 10394915
[TBL] [Abstract][Full Text] [Related]
16. ATP-dependent interaction of human mismatch repair proteins and dual role of PCNA in mismatch repair.
Gu L; Hong Y; McCulloch S; Watanabe H; Li GM
Nucleic Acids Res; 1998 Mar; 26(5):1173-8. PubMed ID: 9469823
[TBL] [Abstract][Full Text] [Related]
17. Expression of DNA mismatch repair genes in naevi.
Korabiowska M; Brinck U; Ruschenburg I; Dengler H; Droese M; Berger H
In Vivo; 1999; 13(3):251-4. PubMed ID: 10459502
[TBL] [Abstract][Full Text] [Related]
18. Brostallicin (PNU-166196)--a new DNA minor groove binder that retains sensitivity in DNA mismatch repair-deficient tumour cells.
Fedier A; Fowst C; Tursi J; Geroni C; Haller U; Marchini S; Fink D
Br J Cancer; 2003 Oct; 89(8):1559-65. PubMed ID: 14562032
[TBL] [Abstract][Full Text] [Related]
19. Characterization of MLH1 and MSH2 DNA mismatch repair proteins in cell lines of the NCI anticancer drug screen.
Taverna P; Liu L; Hanson AJ; Monks A; Gerson SL
Cancer Chemother Pharmacol; 2000; 46(6):507-16. PubMed ID: 11138465
[TBL] [Abstract][Full Text] [Related]
20. Isolation of MutSbeta from human cells and comparison of the mismatch repair specificities of MutSbeta and MutSalpha.
Genschel J; Littman SJ; Drummond JT; Modrich P
J Biol Chem; 1998 Jul; 273(31):19895-901. PubMed ID: 9677427
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]